Cargando…
Macrophages in ovarian cancer and their interactions with monoclonal antibody therapies
The unmet clinical need for effective treatments in ovarian cancer has yet to be addressed using monoclonal antibodies (mAbs), which have largely failed to overcome tumour-associated immunosuppression, restrict cancer growth, and significantly improve survival. In recent years, experimental mAb desi...
Autores principales: | Osborn, Gabriel, Stavraka, Chara, Adams, Rebecca, Sayasneh, Ahmad, Ghosh, Sharmistha, Montes, Ana, Lacy, Katie E, Kristeleit, Rebecca, Spicer, James, Josephs, Debra H, Arnold, James N, Karagiannis, Sophia N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307234/ https://www.ncbi.nlm.nih.gov/pubmed/35020853 http://dx.doi.org/10.1093/cei/uxab020 |
Ejemplares similares
-
Immune cell–antibody interactions in health and disease
por: Karagiannis, Sophia N, et al.
Publicado: (2022) -
Antibodies as biomarkers for cancer risk: a systematic review
por: Monroy-Iglesias, Maria J, et al.
Publicado: (2022) -
Mechanisms of induction of regulatory B cells in the tumour microenvironment and their contribution to immunosuppression and pro-tumour responses
por: Flores-Borja, Fabian, et al.
Publicado: (2022) -
Monoclonal Antibody Against Stromal Cell-Derived Factor 2
Publicado: (2020) -
Clinical and Translational Significance of Basophils in Patients with Cancer
por: Chauhan, Jitesh, et al.
Publicado: (2022)